MeSH D003874 - dermatitis herpetiformis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| AbbVie | Dapsone | Aczone |  | 2005-07-07 |  |  |
| Alembic Pharmaceuticals | Dapsone | Dapsone |  | 2023-10-27 |  |  |
| Allergan | Dapsone | Dapsone |  | 2017-03-23 |  |  |
| Almirall | Dapsone | Aczone | 2033-11-18 | 2016-02-24 |  |  |
| Alvogen | Dapsone | Dapsone |  | 2016-01-07 |  |  |
1
2
3
4
5
6
...
14
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
0%0/0
Phase 3
100%9/9
Approved: 9Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
9
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use